KM survival analysis highlighted that individuals in the NXPH4 high expression group were linked to poorer DSS in ACC, BLCA, BRCA, COAD, GBM, KIRP, GBM, LIHC, MESO, KIRP, UVM, and UCEC (Figure 4B). The gene discussed is NXPH4; the disease is glioblastoma.